Hundreds of HIV doctors and researchers have called on the Trump administration to reverse its sweeping aid funding cuts, saying they are "doing catastrophic harm" to the global fight against AIDS.

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Human rights, key and vulnerable populations Ethiopia received PEPFAR funding for work on stigma, discrimination and enabling legal environments. As a result of the USG stop-work order, all programmes ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Sex Workers, MSM, and Transgender Persons: Disruption in access to PrEP services, reduced capacity for HIV prevention services, , reduced availability of HIV counselling and testing, and disruption in ...

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Without public health surveillance, officials trying to tackle outbreaks, identify threats and evaluate treatments are working ‘in the darkness of ignorance.’ ...

The 20th anniversary theme of #NWGHAAD is “Hope, Health and Healing: Overcoming Barriers to HIV/AIDS Treatment for Women and ...

AHF prioritizes women and girls by advocating for policies that protect and uplift them worldwide. From distributing free ...

AIDS Healthcare Foundation (AHF), in collaboration with the University of Miami Public Health Policy Lab and the Miami Center ...